Foresite Capital Management IV’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.08M | Sell |
|
|||||
|
2025
Q1 | $8.61M | Buy |
|
|||||
|
2024
Q4 | $5.33M | Hold |
|
|||||
|
2024
Q3 | $11.5M | Hold |
|
|||||
|
2024
Q2 | $12.1M | Hold |
|
|||||
|
2024
Q1 | $18.6M | Hold |
|
|||||
|
2023
Q4 | $16.2M | Sell |
|
|||||
|
2023
Q3 | $12.9M | Sell |
|
|||||
|
2023
Q2 | $30.8M | Sell |
|
|||||
|
2023
Q1 | $23.6M | Hold |
|
|||||
|
2022
Q4 | $34.7M | Hold |
|
|||||
|
2022
Q3 | $73.3M | Sell |
|
|||||
|
2022
Q2 | $86.6M | Hold |
|
|||||
|
2022
Q1 | $67.1M | Hold |
|
|||||
|
2021
Q4 | $103M | Hold |
|
|||||
|
2021
Q3 | $197M | Hold |
|
|||||
|
2021
Q2 | $216M | Buy |
|